Shares of Teva Pharmaceutical Industries Ltd. (NYSE:TEVA – Get Free Report) reached a new 52-week high during mid-day trading on Thursday following a better than expected earnings announcement. Teva Pharmaceutical Industries has set its FY 2026 guidance at 2.570-2.770 EPS. Get Teva Pharmaceutical Industries alerts:Key Headlines Impacting Teva Pharmaceutical IndustriesHere are the key news stories impacting Teva Pharmaceutical Industries this week:Analyst Upgrades and DowngradesA number of equities analysts recently commented on the stock. About Teva Pharmaceutical Industries(Get Free Report)Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) is an Israeli multinational pharmaceutical company and one of the world’s largest manufacturers of generic medicines. Featured StoriesReceive News & Ratings for Teva Pharmaceutical Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teva Pharmaceutical Industries and related companies with MarketBeat.com's FREE daily email newsletter.